Pharmacogenetic Determinants Of Treatment Response In Children

RecruitingOBSERVATIONAL

Enrollment

8,800

Participants

Timeline

Start Date

August 17, 1998

Primary Completion Date

December 31, 2033

Study Completion Date

March 31, 2034

Conditions

All MalignanciesChildren Being Treated for Catastrophic Illness

Trial Locations (1)

RECRUITING

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT00730678 - Pharmacogenetic Determinants Of Treatment Response In Children | Biotech Hunter | Biotech Hunter